Published in Medical Letter on the CDC and FDA, June 9th, 2002
Most clinical laboratories surveyed in February 2000 were using appropriate methods for pneumococcal susceptibility testing; however, some inconsistencies with the National Committee for Clinical Laboratory Standards (NCCLS) guidelines were noted.
For isolates from patients with potentially life-threatening infections, laboratories should bypass oxacillin disk...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.